Vanda Pharmaceuticals Inc (VNDA)

02:41 AM

Vanda’s Jet Lag Drug Gets Fresh FDA Look After Court Ruling - Bloomberg Law News

02:41 AM

Aug 14, 2025

Why Vanda Pharmaceuticals Inc. stock attracts strong analyst attentionPortfolio Risk Report & Real-Time Market Trend Scan - Newser

Aug 14, 2025

Aug 13, 2025

Sentiment analysis tools applied to Vanda Pharmaceuticals Inc.2025 Price Momentum & Scalable Portfolio Growth Methods - Newser

Aug 13, 2025

Aug 12, 2025

Vanda Pharmaceuticals Receives Strong Buy Rating Amidst Growth in Key Product Lines and Promising FDA Decision on Bysanti - AInvest

Aug 12, 2025

Aug 08, 2025

Insider Buying: Mihael Polymeropoulos Acquires Additional Shares of Vanda Pharmaceuticals Inc (VNDA) - GuruFocus

Aug 08, 2025

Aug 08, 2025

Vanda Pharmaceuticals CEO Buys 10,000 Shares at $4.15/Share on August 7, 2023. - AInvest

Aug 08, 2025

Aug 08, 2025

Vanda (VNDA) Q2 Revenue Rises 4% - AOL.com

Aug 08, 2025

Aug 05, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) Cut to Strong Sell at Wall Street Zen - Defense World

Aug 05, 2025

Aug 03, 2025

Vanda Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding trading profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Vanda Pharmaceuticals Inc. stockSuperior returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Vanda Pharmaceuticals Inc. stock price move sharplyCapitalize on high-yield stocks early - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Vanda Pharmaceuticals Inc. stock overvalued or undervaluedCapitalize on emerging growth stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Vanda Pharmaceuticals Inc. company’s key revenue driversRapidly growing investment returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Vanda Pharmaceuticals Inc. stockRapid growth trajectories - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Vanda Pharmaceuticals Inc. stock higher in 2025Unlock your portfolio’s full growth potential - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Why is Vanda Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize portfolio value with timely trades - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What are the technical indicators suggesting about Vanda Pharmaceuticals Inc.Maximize your portfolio’s earning power - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Vanda Pharmaceuticals Inc. a growth stock or a value stockDiscover stocks with massive upside potential - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Should I hold or sell Vanda Pharmaceuticals Inc. stock in 2025Phenomenal wealth increase - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How many analysts rate Vanda Pharmaceuticals Inc. as a “Buy”Get professional advice for market timing - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Vanda Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Aug 01, 2025

Aug 01, 2025

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 01, 2025

Aug 01, 2025

Vanda Pharmaceuticals 2025 Q2 Earnings Misses Targets as Net Loss Widens 502% - AInvest

Aug 01, 2025

Aug 01, 2025

Vanda Pharmaceuticals Inc (VNDA) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Rising ... By GuruFocus - Investing.com Canada

Aug 01, 2025

Aug 01, 2025

Vanda Pharmaceuticals Inc (VNDA) Q2 2025 Earnings Call Highlights: Revenue Growth Amid Rising Expenses - GuruFocus

Aug 01, 2025

Aug 01, 2025

Vanda: Q2 Earnings Snapshot - Norwalk Hour

Aug 01, 2025

Jul 31, 2025

Vanda Pharmaceuticals' Q2 2025: Navigating Contradictions in Bysanti, PONVORY, and DTC Strategies - AInvest

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat

Jul 31, 2025

Jul 31, 2025

Earnings call transcript: Vanda Pharmaceuticals Q2 2025 misses EPS and revenue forecasts - Investing.com Nigeria

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals: Navigating Q2 Earnings Disappointment Amid High-Stakes Pipeline Progress - AInvest

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals Sees Strong Fanapt Growth Despite Rising Losses - Finimize

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals Q2 2025 Earnings: EPS Misses at -$0.46, Revenue Falls Short at $52.6 Million - GuruFocus

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals' Q2 2025 Earnings: A Turning Point in Pipeline Execution and Commercialization - AInvest

Jul 31, 2025

Jul 31, 2025

Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results - ADVFN Brasil

Jul 31, 2025

Jul 31, 2025

How volatile is Vanda Pharmaceuticals Inc. stock compared to the marketMarket Forecast Data Feed Backed By Experts - jammulinksnews.com

Jul 31, 2025

Jul 30, 2025

Exploring US High Growth Tech Stocks For Potential Portfolio Expansion - simplywall.st

Jul 30, 2025

Jul 29, 2025

How Vanda Pharmaceuticals Inc. stock performs during market volatilityExit Ready Momentum Stock Watchlist Expanded - metal.it

Jul 29, 2025

Jul 29, 2025

Price Channel Expanding on Vanda Pharmaceuticals Inc.’s ChartROI Boosting Trade Opportunity Calendar Published - metal.it

Jul 29, 2025

Jul 29, 2025

Vanda Pharmaceuticals Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView

Jul 29, 2025

Jul 29, 2025

Bronstein, Gewirtz & Grossman, LLC Class Action Update Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Syneos Health, Inc. (SYNH) - ACCESS Newswire

Jul 29, 2025

Jul 29, 2025

Investor Network: Vanda Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Jul 29, 2025